INS and metabolic dysfunction-associated steatotic liver disease: In this physiologic scenario, the impaired lipolysis of triglycerides from insulin-resistant adipose tissue represents a major driver of fatty acid accumulation into the liver from the blood and is a key factor for MASLD development [16,17,18,19].